NEW YORK (GenomeWeb) – OncoDNA announced today that it will help perform patient stratification in a Phase II precision medicine study in head and neck cancer being run by the European Organization for Research and Treatment of Cancer.
NEW YORK (GenomeWeb) – OncoDNA announced today that it will help perform patient stratification in a Phase II precision medicine study in head and neck cancer being run by the European Organization for Research and Treatment of Cancer.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.